Manufacturing - Chemicals Pharma & Life Sciences

M&A Sell-Side Businesses For Sale

Price
KazakhstanKazakhstanManufacturingL#20261174

Central Asian Chlor-Alkali & Chemicals Manufacturing Platform

The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, competitive operating fundamentals, and strategic Eurasian logistics corridors, the project is structured to substitute…

Target Price$1,000,000,000
Revenue$620,000,000
EBITDA$186,000,000
United StatesUnited StatesManufacturingL#20261103

American Leading Life Sciences Research Services Platform

A leading independent multi-omics service providers in the Americas. The Company provides a comprehensive portfolio of next-generation sequencing (NGS), proteomics, metabolomics, epigenomics, and bioinformatics solutions to research institutions, hospitals, biotechnology companies, and pharmaceutical clients across North and South America. Following…

Target Price$44,000,000
Revenue$57,000,000
EBITDA$3,700,000
KazakhstanKazakhstanManufacturingL#20261174

Central Asian Chlor-Alkali & Chemicals Manufacturing Platform

The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, competitive operating fundamentals, and strategic Eurasian logistics corridors, the project is structured to substitute…

Target Price
$1,000,000,000
Revenue
$620,000,000
EBITDA
$186,000,000
United StatesUnited StatesManufacturingL#20261103

American Leading Life Sciences Research Services Platform

A leading independent multi-omics service providers in the Americas. The Company provides a comprehensive portfolio of next-generation sequencing (NGS), proteomics, metabolomics, epigenomics, and bioinformatics solutions to research institutions, hospitals, biotechnology companies, and pharmaceutical clients across North and South America. Following…

Target Price
$44,000,000
Revenue
$57,000,000
EBITDA
$3,700,000
Select Listing IDNameTarget PriceRevenueEBITDA Revenue
Multiple
EBITDA
Multiple
IndustryCountryOpen
L#20261215113-Acre Ohio Riverfront Chemical Processing & Heavy Industrial Redevelopment Opportunity$40,000,000TBDTBDManufacturingUnited StatesUnited States
L#20261174Central Asian Chlor-Alkali & Chemicals Manufacturing Platform$1,000,000,000$620,000,000$186,000,0001.61x5.38xManufacturingKazakhstanKazakhstan
L#20261103American Leading Life Sciences Research Services Platform$44,000,000$57,000,000$3,700,0000.77x11.89xManufacturingUnited StatesUnited States
L#20261029Established Italian Producer of Industrial & Consumer Chemical Solutions€4,500,000€5,100,000€1,250,0000.88x3.6xManufacturingItalyItaly
L#20240741Industrial Cannabis Grow and processing facility Center$25,000,000TBDTBDManufacturingUnited StatesUnited States
L#20230574Leading Cannabis Producer with Over 100 Franchise Shops Across Europe€15,000,000€3,750,000€800,0004x18.75xManufacturingItalyItaly
L#2021001340 Year Old Pharmaceutical Manufacturing Business$40,000,000$25,000,000$3,000,0001.6x13.33xManufacturingIndiaIndia

Disclaimer : All information contained in this page may subsequently be updated and adjusted. MergersUS Inc. has not independently verified any of the information contained herein or on which this page is based. Neither the Company, nor its management or shareholders, nor MergersUS Inc. , nor any of their respective directors, partners, officers, employees or affiliates make any representation or warranty (express or implied) or accept or will accept any responsibility or liability regarding or in relation to the accuracy or completeness of the information contained in this page or any other written or oral information made available to any interested party or its advisers. Any liability in respect of any such information or any inaccuracy in or omission from the document is expressly disclaimed.